₹618.60
−0.10%NSE close, 16 Nov 2026
−21.43%
Medplus Health Services is a small cap company in the Consumer Services sector, listed on NSE under the symbol MEDPLUS. At ₹618.60 a share, the market values the whole company at ₹7,432 crore.
In FY26, it reported sales of ₹6,892 crore and a net profit of ₹220 crore, an operating margin of 8.8%. Over the last three years, sales grew 22.2% a year and net profit grew 31.9% a year.
The market values the company at 35.2 times its profit over the last twelve months and 3.59 times its book value; its return on equity is 10.2% and it has almost no borrowings.
Promoters hold 40.19% of the shares, and have pledged 74.1% of their holding. Foreign institutions hold 12.58%, and domestic institutions, mutual funds among them, 31.89%.
Over the past year the share price has fallen 21.2%, and it is 39.5% below its 52-week high.
Companies of a similar size in the same sector include BLS International Services, Entero Healthcare Solutions, Brainbees Solutions and Aditya Vision.
₹ crore. Consolidated figures.
The same sector (Consumer Services), nearest in size.
| Company | Price | Market cap | P/E | ROE | Sales growth | 1Y |
|---|---|---|---|---|---|---|
| Medplus Health Services | ₹618.60 | ₹7,432 cr | 35.2 | 10.2% | +21.30% | −21.21% |
| BLS International Services | ₹225.07 | ₹9,267 cr | 12.9 | 25.4% | +32.00% | −29.53% |
| Entero Healthcare Solutions | ₹1,963.60 | ₹8,546 cr | 61.3 | 7.8% | +32.90% | +85.67% |
| Brainbees Solutions | ₹158.59 | ₹8,280 cr | n/a | -2.0% | +14.10% | −53.95% |
| Aditya Vision | ₹569.10 | ₹7,349 cr | 50.9 | 18.8% |
Intimation of Schedule of Analyst / Institutional Investor Meeting
Written from the company's filings with NSE and the exchanges' daily prices. For information only, not a recommendation to buy, sell or hold any security.
| Mar 2026 |
|---|
| Jun 2026 |
|---|
| Sep 2026 |
|---|
| Sales | 1,441 | 1,491 | 1,489 | 1,576 | 1,561 | 1,510 | 1,543 | 1,679 | 1,806 | 1,864 | 1,880 | 2,037 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Expenses | 1,350 | 1,385 | 1,395 | 1,452 | 1,429 | 1,373 | 1,412 | 1,530 | 1,648 | 1,695 | 1,746 | 1,867 |
| Operating profit | 91.8 | 106 | 93.8 | 124 | 133 | 136 | 131 | 149 | 159 | 169 | 133 | 170 |
| Operating margin | 6.4% | 7.1% | 6.3% | 7.9% | 8.5% | 9.0% | 8.5% | 8.9% | 8.8% | 9.1% | 7.1% | 8.3% |
| Other income | 9.8 | 10.5 | 8.7 | 11.6 | 12.5 | 15.8 | 15.0 | 17.5 | 18.2 | 20.6 | 19.8 | 20.5 |
| Interest | 24.5 | 25.1 | 24.7 | 25.1 | 26.0 | 26.8 | 27.4 | 28.8 | 30.8 | 33.5 | 33.3 | 36.6 |
| Depreciation | 57.1 | 59.2 | 60.0 | 63.1 | 62.5 | 64.2 | 65.6 | 68.6 | 72.7 | 76.0 | 77.9 | 83.8 |
| Profit before tax | 20.0 | 32.0 | 17.8 | 47.8 | 56.6 | 61.1 | 52.8 | 68.9 | 73.3 | 80.3 | 41.9 | 70.2 |
| Tax | 6.3 | −1.6 | 3.4 | 9.1 | 10.7 | 9.8 | 10.4 | 13.4 | 15.5 | 16.4 | 8.7 | 14.1 |
| Net profit | 13.7 | 33.4 | 14.4 | 38.7 | 45.9 | 51.3 | 42.4 | 55.5 | 57.8 | 64.0 | 33.2 | 56.1 |
| EPS (₹) | 1.15 | 2.81 | 1.20 | 3.24 | 3.84 | 4.32 | 3.54 | 4.63 | 4.82 | 5.33 | 2.76 | 4.73 |
₹ crore, financial years to March.
| Line | FY22 | FY23 | FY25 | FY26 |
|---|---|---|---|---|
| Sales | 3,779 | 4,558 | 6,136 | 6,892 |
| Expenses | 3,507 | 4,292 | 5,649 | 6,285 |
| Operating profit | 272 | 266 | 487 | 607 |
| Operating margin | 7.2% | 5.8% | 7.9% | 8.8% |
| Other income | 31.4 | 46.1 | 48.6 | 71.3 |
| Interest | 66.4 | 83.0 | 103 | 120 |
| Depreciation | 119 | 182 | 250 | 283 |
| Profit before tax | 118 | 47.2 | 183 | 275 |
| Tax | 23.2 | −2.9 | 33.1 | 55.7 |
| Net profit | 95.8 | 49.8 | 150 | 220 |
| EPS (₹) | 8.55 | 4.18 | 12.57 | 18.33 |
₹ crore, at each year's end and the latest half year.
₹ crore, by financial year, and the latest half year.
| Line | FY22 | FY25 | FY26 | 6M to Sep 2026 |
|---|---|---|---|---|
| From operations | 170 | 540 | 496 | 162 |
| From investing | −703 | −318 | −128 | −65.6 |
| From financing | 440 | −228 | −256 | −150 |
| Spent on fixed assets | −118 | −59.5 | −123 | −77.5 |
| Free cash flow | 52.2 | 481 | 373 | 84.7 |
Margins, returns, debt, tax and cash.
| Line | FY22 | FY23 | FY25 | FY26 |
|---|---|---|---|---|
| Net margin | 2.5% | 1.1% | 2.4% | 3.2% |
| Operating margin | 7.2% | 5.8% | 7.9% | 8.8% |
| Return on equity | – | 3.3% | 8.6% | 11.1% |
| Return on capital employed | – | 8.7% | 16.4% | 20.0% |
| Return on assets | – | 1.8% | 4.5% | 5.6% |
| Debt to equity | – | 0.00 | 0.00 | 0.00 |
| Interest coverage | 2.80 | 1.60 | 2.80 | 3.30 |
| Debt to assets | – | 0.00 | 0.00 | 0.00 |
| Current ratio | – | 3.11 | 3.20 | 3.00 |
| Quick ratio | – | 0.71 | 0.86 | 1.00 |
| Cash ratio | – | 0.48 | 0.15 | 0.29 |
| Asset turnover | – | 1.63 | 1.83 | 1.75 |
| Fixed asset turnover | – | 15.81 | 21.11 | 21.65 |
| Inventory turnover | – | – | 3.50 | 3.70 |
| Receivables turnover | – | 526.90 | 462.40 | 255.70 |
| Gross margin | – | – | 24.4% | 26.2% |
| Cash from operations to profit | 177.0% | – | 360.0% | 226.0% |
| Effective tax rate | 19.7% | – | 18.0% | 20.2% |
| +28.10% |
| +6.01% |
| Le Travenues Technology | ₹165.86 | ₹7,316 cr | 48.9 | 6.9% | +13.50% | −39.96% |
|---|
| Sapphire Foods India | ₹207.53 | ₹6,670 cr | n/a | -0.3% | +19.60% | −25.62% |
|---|
| Restaurant Brands Asia | ₹90.88 | ₹6,471 cr | n/a | -7.9% | +20.10% | +35.80% |
|---|
| V-Mart Retail | ₹792.50 | ₹6,306 cr | 48.5 | 13.3% | +18.10% | −3.34% |
|---|
Submission of Audio Recordings of Earnings Call
Allotment of equity shares under the MedPlus Employee Stock Option Plan, 2021 ( ESOP 2021 )
Outcome of Board meeting under SEBI (Listing Obligation and Disclosure requirements)Regulations 2015 (Listing Regulations)
Schedule of meet
Board comments on fine levied by the Exchange
Outcome of Board Meeting held on September 10, 2026.
A copy Srutinizers report of Annual General Meeting held on August 17, 2026. Further, the company has informed the Exchange regarding voting results.
Summary Proceedings of Annual General Meeting held on August 17, 2026